|
DE144266C
(OSRAM)
|
|
|
|
|
|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3177206A
(en)
|
1963-03-07 |
1965-04-06 |
American Home Prod |
Selective bromination of a-ring aromatic 17-ketalized steroids
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US3673180A
(en)
|
1970-06-18 |
1972-06-27 |
Merck & Co Inc |
19-nor-6,6-ethylene-20-spiroxenes
|
|
US4792620A
(en)
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
|
US4739078A
(en)
|
1984-02-17 |
1988-04-19 |
The Upjohn Company |
Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
|
|
IE60780B1
(en)
|
1987-01-23 |
1994-08-10 |
Akzo Nv |
New 11-aryl steroid derivatives
|
|
DE3710728A1
(de)
|
1987-03-31 |
1988-10-13 |
Schering Ag |
Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
US8048869B2
(en)
|
2001-05-18 |
2011-11-01 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
|
DK1390042T3
(da)
|
2001-05-23 |
2008-03-31 |
Pantarhei Bioscience Bv |
System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse
|
|
EP1390041B1
(en)
|
2001-05-23 |
2009-11-25 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
CA2467222C
(en)
|
2001-11-15 |
2010-06-08 |
Herman Jan Tijmen Coelingh Bennink |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
CA2476940C
(en)
|
2002-02-21 |
2011-11-01 |
Herman Jan Tijmen Coelingh Bennink |
Pharmaceutical compositions comprising one or more steroids, one or more tetrahydrofolate components and vitamin b12
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
US7943604B2
(en)
|
2002-06-11 |
2011-05-17 |
Pantarhei Bioscience B.V. |
Method of treating human skin and a skin care composition for use in such a method
|
|
CN1691947B
(zh)
|
2002-06-11 |
2011-11-23 |
潘塔希生物科学股份有限公司 |
雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物
|
|
CA2492287C
(en)
|
2002-07-12 |
2011-12-13 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
|
|
CN100528167C
(zh)
|
2002-10-23 |
2009-08-19 |
潘塔希生物科学股份有限公司 |
用于治疗癌症的包含雌四醇衍生物的药物组合物
|
|
ATE469165T1
(de)
*
|
2002-11-08 |
2010-06-15 |
Pantarhei Bioscience Bv |
Synthese von oestetrol aus von oestron abgeleiteten steroiden
|
|
DK1624878T3
(da)
|
2003-05-22 |
2007-01-08 |
Pantarhei Bioscience Bv |
Anvendelse af præparater som omfatter en östrogen komponent til behandling og forebyggelse af muskel-skelet-smerte
|
|
JP5268635B2
(ja)
|
2005-05-26 |
2013-08-21 |
アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１７β−ＨＳＤ１及びＳＴＳインヒビター
|
|
EP2077322B1
(de)
|
2005-07-25 |
2010-08-25 |
RiboxX GmbH |
Verfahren und Kit zur Amplifikation von heteropolymerer oder poly(C)- RNA
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
CA2636638C
(en)
|
2006-01-09 |
2014-02-18 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
ES2659316T3
(es)
|
2006-06-08 |
2018-03-14 |
Allergan Pharmaceuticals International Limited |
Procedimientos para administrar formas de dosificación sólidas de etinilestradiol y profármacos del mismo con biodisponibilidad mejorada
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
GB0621926D0
(en)
|
2006-11-03 |
2006-12-13 |
Medlock Medical Ltd |
Multi directional stretch tubular bandages
|
|
CA2670544A1
(en)
|
2006-11-29 |
2008-06-05 |
Wyeth |
Estrogen/ serm and estrogen/ progestin bi-layer tablets
|
|
CA2674776A1
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
US8236785B2
(en)
|
2007-01-08 |
2012-08-07 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
|
PE20081632A1
(es)
|
2007-01-12 |
2008-12-10 |
Wyeth Corp |
Composiciones de tableta en tableta
|
|
CN102014924B
(zh)
|
2007-06-21 |
2012-07-18 |
潘塔希生物科学股份有限公司 |
用雌激素治疗胎粪吸入综合征
|
|
WO2009011576A1
(en)
|
2007-07-19 |
2009-01-22 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
EP2085373B8
(en)
|
2007-08-31 |
2013-06-26 |
National University Corporation Nagoya University |
Method for producing carbonyl compound and pro-oxidant used for production of carbonyl compound
|
|
EP2077272A1
(en)
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
|
US20110250274A1
(en)
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
AU2012264601C1
(en)
|
2011-06-01 |
2018-01-25 |
Estetra Srl |
Process for the production of estetrol intermediates
|
|
PT2714710T
(pt)
|
2011-06-01 |
2016-07-12 |
Estetra Sprl |
Processo para a produção de intermediários de estetrol
|
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
WO2013012326A1
(en)
|
2011-07-19 |
2013-01-24 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (dhea)
|
|
HRP20170797T1
(hr)
|
2011-08-11 |
2017-08-11 |
Estetra S.P.R.L. |
Primjena estetrola kao hitnog kontraceptiva
|
|
NZ620897A
(en)
|
2011-09-16 |
2016-07-29 |
Ferring Bv |
A fast dissolving pharmaceutical composition
|
|
EP2764008B1
(en)
|
2011-10-07 |
2016-08-17 |
Estetra S.P.R.L. |
Process for the production of estetrol
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
CA2924255C
(en)
|
2013-09-18 |
2022-11-22 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
|
KR102265150B1
(ko)
|
2013-12-12 |
2021-06-16 |
에스테트라 에스.피.알.엘. |
에스테트롤 성분을 함유하는 구강 붕해성 고체 투여 단위
|
|
MY195019A
(en)
|
2015-06-18 |
2023-01-03 |
Estetra Sprl |
Orodispersible dosage unit containing an estetrol component
|
|
MD3310346T2
(ro)
|
2015-06-18 |
2021-06-30 |
Estetra Sprl |
Comprimată orodispersabilă ce conține estetrol
|
|
HUE054589T2
(hu)
|
2015-06-18 |
2021-09-28 |
Estetra Sprl |
Szájban diszpergálódó esztetrol tartalmú tabletta
|
|
JP6866560B2
(ja)
|
2015-06-18 |
2021-04-28 |
エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ |
エステトロール成分を含有する口腔内崩壊性投与単位
|